Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
Clinical trials during a pandemic – lessons from COVID-19

Clinical trials during a pandemic – lessons from COVID-19

Scientists restore memory in aging mice

Scientists restore memory in aging mice

New OMV-based COVID-19 vaccine candidate proves effective in mice

New OMV-based COVID-19 vaccine candidate proves effective in mice

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Gene therapy shows promise in children with devastating genetic disorder

Gene therapy shows promise in children with devastating genetic disorder

Novel method of gene therapy promises to transform the treatment of rare genetic disorder

Novel method of gene therapy promises to transform the treatment of rare genetic disorder

COVID-19 recovered vaccinated individuals more protected from Delta variant

COVID-19 recovered vaccinated individuals more protected from Delta variant

PerkinElmer to buy SIRION Biotech

PerkinElmer to buy SIRION Biotech

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Immune cell-mimicking nanoparticles deliver drugs directly to inflamed lungs

Immune cell-mimicking nanoparticles deliver drugs directly to inflamed lungs

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

SARS-CoV-2 oral vaccine booster shows promise in animal tests

SARS-CoV-2 oral vaccine booster shows promise in animal tests

Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants

Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Researchers develop proof-of-concept treatment for blood disorders

Researchers develop proof-of-concept treatment for blood disorders

Study shows CoronaVac to have high seroconversion rate after 40 days

Study shows CoronaVac to have high seroconversion rate after 40 days

Researchers identify aluminum hydroxide/TLR9 agonist as potential adjuvant to improve RBD-based COVID-19 vaccine efficacy

Researchers identify aluminum hydroxide/TLR9 agonist as potential adjuvant to improve RBD-based COVID-19 vaccine efficacy

Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

Experimental gene therapy successfully treats children born without an immune system

Experimental gene therapy successfully treats children born without an immune system